Adalimumab 61314-0325-20
Generic: Adalimumab-Adaz
- Manufacturer
- Sandoz Inc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 6, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761071
Need to source Adalimumab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab | 80 mg/.8mL |
Drug Class
Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]
Selected Package
61314-0325-20Selected2 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE